Your browser doesn't support javascript.
loading
A retrospective observational study of a low fixed-dose rasburicase protocol for the treatment of tumor lysis syndrome in adults.
Hossain, Shahrier; Naber, Martha; Yacobucci, Matthew J.
Affiliation
  • Hossain S; Department of Pharmacy, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Naber M; Department of Pharmacy, Albany Medical Center Hospital, Albany, NY, USA.
  • Yacobucci MJ; Department of Pharmacy, Albany Medical Center Hospital, Albany, NY, USA.
J Oncol Pharm Pract ; 28(6): 1326-1331, 2022 Sep.
Article in En | MEDLINE | ID: mdl-34115548
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Lysis Syndrome / Hyperuricemia Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2022 Document type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Lysis Syndrome / Hyperuricemia Type of study: Etiology_studies / Guideline / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: J Oncol Pharm Pract Journal subject: FARMACIA Year: 2022 Document type: Article Affiliation country: United States